Back to results
US 12,239,698 B2Granted
HIV vaccine immunogens
AssigneesThe Rockefeller University, California Institute of Technology
InventorsMichel Nussenzweig, Pamela J. Bjorkman, Amelia Escolano, Harry Gristick
Life of this patent
Estimating the term…
Abstract
This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
Claims14
An isolated polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 2, 4, 6, 8, 11, and 13.
Dependencies are inferred from the claim text.